Trial Profile
Phase II study of dose-escalation of Regorafenib for patients with previously treated metastatic colorectal cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2020
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms DEREGULATE
- 30 Jul 2014 New trial record